Expanding Horizons in Clinical Research
"Türkiye is making significant strides in clinical research through innovative solutions and adherence to international standards. Let’s take this journey together!"
Türkiye's Growing Role in Clinical Research
In recent years, Türkiye has experienced a remarkable transformation in the field of clinical research, gaining international recognition with its rapidly developing infrastructure, skilled experts, and strong regulatory framework. With a commitment to innovative solutions, Türkiye is emerging as a robust player in the global clinical research ecosystem.
Why Türkiye?
• Compliance with International Standards:
Turkey adheres to globally recognized clinical research standards, earning a reputable position within the global research network. Both local and international companies benefit from Turkey’s robust regulatory framework and scientific infrastructure to conduct high-quality research.
This strong growth translates into more opportunities, reliable data, and global collaborations in clinical research.
• A Strong Future with Innovative Solutions:
By implementing innovative solutions in clinical research, Turkey accelerates research processes while enhancing the reliability of results. This vision not only increases research capacity but also integrates technologies and digital solutions effectively into the research process.
• A Broad Network of Experienced Researchers:
Turkey boasts a large pool of highly qualified and specialized researchers with extensive experience across all phases of clinical research. This team is capable of managing research processes efficiently, ensuring the collection of high-quality data in compliance with international standards. Turkish researchers lead clinical studies with expertise and innovative approaches, driving progress in the sector.
Let’s Expand Horizons Together in Clinical Research!
The rapidly growing global clinical research market presents a significant opportunity for Turkey. With the global clinical trials sector expected to surpass $70 billion by 2027, Turkey must take strategic steps to secure its share of this growth. In addition to traditional markets, focusing on new industry segments and emerging markets—particularly by supporting start-up pharmaceutical companies—will strengthen Turkey's position on the global stage.
Expanding into New Markets and Sectors
1. Focusing on Start-Up Pharmaceutical Companies
By offering innovative and flexible solutions, we can create an attractive environment for
start-up pharmaceutical companies with high growth potential. Start-ups operating in fields such as biotechnology and genetic engineering can leverage Turkey's high-quality clinical research infrastructure. This will position
Turkey as a global player in next-generation drug development processes.
2. Integration into Emerging Markets
Turkey should strengthen its integration into rapidly growing markets such as Southeast Asia, Latin
America, and Africa. In these regions, healthcare investments are rapidly increasing, and the demand for clinical research is rising. By establishing an effective collaboration strategy in these markets, we can position
Turkey as a reliable partner in clinical research.
3. Sector Diversification: Digital Health, Telemedicine, and Decentralized Trials
Turkey should strengthen its integration into rapidly growing markets such as Southeast Asia, Latin America, and Africa. In these regions, healthcare investments are rapidly increasing, and the demand for clinical research is rising. By establishing an effective collaboration strategy in these markets, we can position Turkey as a reliable partner in clinical research.
Strategic Steps: Accelerating Processes and Enhancing Investment Appeal
• Faster Response Times and Streamlined Processes
Closer collaboration with ethics committees and the Turkish Medicines and Medical Devices Agency (TITCK), predefined workflows, and ready-to-use standard
contract structures will position Turkey as a preferred clinical research hub for international companies.
• Support and Incentives for New Markets
Financial incentives, dedicated funds, and infrastructure support tailored to start-up pharmaceutical companies can increase their interest in operating in Türkiye.
These measures will serve as critical tools in attracting international companies to choose Turkey for their new projects
Join Us in Making Türkiye the Global Hub for Clinical Research!
Whether you are a government agency, clinical center, principal investigator, pharmaceutical company, CRO, or SMO representative, we invite you to be part of our vision to expand clinical research opportunities in Turkey. Together, let's take strategic steps to bring innovative treatments to broader markets. By accelerating processes and integrating into new markets and sectors, we can work collaboratively to grow Turkey's share in the global clinical research landscape.
